Avalyn Pharma Inc. Common Stock (AVLN) is a publicly traded the market company. As of August 12, 2026, AVLN trades at $35.46 with a market cap of $1.53B and a P/E ratio of 0.00. AVLN moved +0.00% today. Year to date, AVLN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $24.15 to $35.84. Analyst consensus is strong buy with an average price target of $52.00. Rallies surfaces AVLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover AVLN: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $52.00.
| Metric | Value |
|---|---|
| Price | $35.46 |
| Market Cap | $1.53B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $35.84 |
| 52-Week Low | $24.15 |
| Volume | 216 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover AVLN: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $52.00.